References
ChEMBL http://www.ebi.ac.uk/chembl/. Accessed November 2008
Overington JP, Al-Lazikani B, Hopkins AL (2006)) Nat Rev Drug Discov 5:993. doi:10.1038/nrd2199
Agüero F, Al-Lazikani B, Aslett M, Berriman M, Buckner FS, Campbell RK et al (2008) Nat Rev Drug Discov 7:900. doi:10.1038/nrd2684
ChEBI http://www.ebi.ac.uk/chebi/. Accessed November 2008
Steinbeck C, Han Y, Kuhn S, Horlacher O, Luttmann E, Willighagen E (2003) J Chem Inf Comput Sci 43:493. doi:10.1021/ci025584y
Steinbeck C, Hoppe C, Kuhn S, Floris M, Guha R, Willighagen EL (2006) Curr Pharm Des 12:2111. doi:10.2174/138161206777585274
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Warr, W.A. ChEMBL. An interview with John Overington, team leader, chemogenomics at the European Bioinformatics Institute Outstation of the European Molecular Biology Laboratory (EMBL-EBI). J Comput Aided Mol Des 23, 195–198 (2009). https://doi.org/10.1007/s10822-009-9260-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10822-009-9260-9